Array Biopharma Announces Successful Phase 3 Results In Patients With Melanoma

Shares of ARRY gained 80% after positive phase 3 results
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.